Pseudomonas aeruginosa and the host pulmonary immune response - PubMed (original) (raw)
Pseudomonas aeruginosa and the host pulmonary immune response
Patricia J Dubin et al. Expert Rev Respir Med. 2007 Aug.
Abstract
Pseudomonas aeruginosa is a highly adaptable, opportunistic pathogen that is commonly found in the environment. It can infect a number of sites in the body and disseminate. It can cause both acute and chronic pulmonary infection and the acuity of infection and accompanying inflammatory phenotype is determined, for the most part, by the host. Although P. aeruginosa has been a successful opportunist in the context of a number of different disease states, it has been best studied in the context of cystic fibrosis (CF). The adaptability of P. aeruginosa has enabled it to adjust quickly to the CF airway, transitioning from initial colonization to chronic infection. The organism quickly expresses virulence factors that allow it to circumvent some elements of the host immune response and, even more importantly, quickly develops antimicrobial resistance. In the case of CF, chronic infection resulting in progressive lung damage, coupled with antimicrobial resistance, becomes an increasingly important issue as individuals with CF live longer. It is for these reasons that both organism- and host-targeted immunotherapies are being increasingly explored.
Similar articles
- Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients.
Murray TS, Egan M, Kazmierczak BI. Murray TS, et al. Curr Opin Pediatr. 2007 Feb;19(1):83-8. doi: 10.1097/MOP.0b013e3280123a5d. Curr Opin Pediatr. 2007. PMID: 17224667 Review. - Pseudomonas aeruginosa: role in the pathogenesis of the CF lung lesion.
Currie AJ, Speert DP, Davidson DJ. Currie AJ, et al. Semin Respir Crit Care Med. 2003 Dec;24(6):671-80. doi: 10.1055/s-2004-815663. Semin Respir Crit Care Med. 2003. PMID: 16088583 - Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis.
Pedersen SS. Pedersen SS. APMIS Suppl. 1992;28:1-79. APMIS Suppl. 1992. PMID: 1449848 Review. - Emergence and persistence of Pseudomonas aeruginosa in the cystic fibrosis airway.
Fick RB Jr, Sonoda F, Hornick DB. Fick RB Jr, et al. Semin Respir Infect. 1992 Sep;7(3):168-78. Semin Respir Infect. 1992. PMID: 1475541 Review.
Cited by
- Monomethylarsonous Acid (MMAIII) Has an Adverse Effect on the Innate Immune Response of Human Bronchial Epithelial Cells to Pseudomonas aeruginosa.
Notch EG, Goodale BC, Barnaby R, Coutermarsh B, Berwin B, Taylor VF, Jackson BP, Stanton BA. Notch EG, et al. PLoS One. 2015 Nov 10;10(11):e0142392. doi: 10.1371/journal.pone.0142392. eCollection 2015. PLoS One. 2015. PMID: 26554712 Free PMC article. - Homeostatic regulation of Salmonella-induced mucosal inflammation and injury by IL-23.
Awoniyi M, Miller SI, Wilson CB, Hajjar AM, Smith KD. Awoniyi M, et al. PLoS One. 2012;7(5):e37311. doi: 10.1371/journal.pone.0037311. Epub 2012 May 18. PLoS One. 2012. PMID: 22624013 Free PMC article. - Interleukin-17 Is Required for Control of Chronic Lung Infection Caused by Pseudomonas aeruginosa.
Bayes HK, Ritchie ND, Evans TJ. Bayes HK, et al. Infect Immun. 2016 Nov 18;84(12):3507-3516. doi: 10.1128/IAI.00717-16. Print 2016 Dec. Infect Immun. 2016. PMID: 27698020 Free PMC article. - T helper cell subsets specific for Pseudomonas aeruginosa in healthy individuals and patients with cystic fibrosis.
Bayes HK, Bicknell S, MacGregor G, Evans TJ. Bayes HK, et al. PLoS One. 2014 Feb 27;9(2):e90263. doi: 10.1371/journal.pone.0090263. eCollection 2014. PLoS One. 2014. PMID: 24587305 Free PMC article.
LinkOut - more resources
Full Text Sources